Latest Articles

Publication Date
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
20 chocolate Easter eggs later: A nutritionist’s sweet survival guide to see you through the holiday weekend - The Irish News

20 chocolate Easter eggs later: A nutritionist’s sweet survival guide to see you through the holiday weekend The Irish News

Published: April 17, 2025, 5 a.m.
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma MedPage Today

Published: April 9, 2025, 3:15 p.m.
After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... - MSN

After comparing endometrial cancer minimally invasive surgery, laparotomy, survival rate and complications... MSN

Published: April 9, 2025, 12:35 a.m.
Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer - 2 Minute Medicine

Lenvatinib plus pembrolizumab not associated with improved survival compared to standard therapy for recurrent endometrial cancer 2 Minute Medicine

Published: March 17, 2025, 11:07 p.m.
Robotic-assisted laparoscopy increases endometrial cancer survival rates - Contemporary Obgyn

Robotic-assisted laparoscopy increases endometrial cancer survival rates Contemporary Obgyn

Published: March 13, 2025, 5:15 p.m.
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients - Nature.com

Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients Nature.com

Published: March 6, 2025, 6:11 a.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.
Risk factors, survival analysis, and nomograms for high-grade endometrial stromal sarcoma patients with distant metastasis: A population-based study (2010-2019) - Frontiers

Risk factors, survival analysis, and nomograms for high-grade endometrial stromal sarcoma patients with distant metastasis: A population-based study (2010-2019) Frontiers

Published: Feb. 24, 2025, 1:38 p.m.
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab - Physician's Weekly

Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab Physician's Weekly

Published: Feb. 4, 2025, 11:09 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!